Doheny, D., Sirkisoon, S., Carpenter, R. L., Aguayo, N. R., Regua, A. T., Anguelov, M., … Lo, H.-W. (2024). Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene, 43(23), 1811. https://doi.org/10.1038/s41388-024-03046-9

Doheny, Daniel, Sherona Sirkisoon, Richard L. Carpenter, Noah Reeve Aguayo, Angelina T. Regua, Marlyn Anguelov, Sara G. Manore, et al. “Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.” Oncogene 43, no. 23 (June 2024): 1811. https://doi.org/10.1038/s41388-024-03046-9.

Doheny D, Sirkisoon S, Carpenter RL, Aguayo NR, Regua AT, Anguelov M, et al. Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene. 2024 Jun;43(23):1811.

Doheny, Daniel, et al. “Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.” Oncogene, vol. 43, no. 23, June 2024, p. 1811. Pubmed, doi:10.1038/s41388-024-03046-9.

Doheny D, Sirkisoon S, Carpenter RL, Aguayo NR, Regua AT, Anguelov M, Manore SG, Arrigo A, Jalboush SA, Wong GL, Yu Y, Wagner CJ, Chan M, Ruiz J, Thomas A, Strowd R, Lin J, Lo H-W. Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene. 2024 Jun;43(23):1811.